IDEAYA Biosciences (IDYA) EBIAT (2020 - 2025)
Historic EBIAT for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $119.2 million.
- IDEAYA Biosciences' EBIAT rose 33010.75% to $119.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$115.7 million, marking a year-over-year increase of 3506.57%. This contributed to the annual value of -$274.5 million for FY2024, which is 14298.39% down from last year.
- IDEAYA Biosciences' EBIAT amounted to $119.2 million in Q3 2025, which was up 33010.75% from -$130.3 million recorded in Q4 2024.
- In the past 5 years, IDEAYA Biosciences' EBIAT registered a high of $119.2 million during Q3 2025, and its lowest value of -$130.3 million during Q4 2024.
- Its 5-year average for EBIAT is -$22.2 million, with a median of -$23.6 million in 2023.
- As far as peak fluctuations go, IDEAYA Biosciences' EBIAT tumbled by 179907.12% in 2023, and later surged by 33010.75% in 2025.
- Quarter analysis of 5 years shows IDEAYA Biosciences' EBIAT stood at -$18.2 million in 2021, then crashed by 32.88% to -$24.2 million in 2022, then plummeted by 40.3% to -$34.0 million in 2023, then crashed by 283.78% to -$130.3 million in 2024, then skyrocketed by 191.51% to $119.2 million in 2025.
- Its EBIAT stands at $119.2 million for Q3 2025, versus -$130.3 million for Q4 2024 and -$51.8 million for Q3 2024.